Development of plasma cell dyscrasias in a patient with chronic myeloid leukemia: A case report

por Zhang, Na, Jiang, Ting-De, Yi, Shu-Hua
Publicado 2022

TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia

por Zhang, Yan-Ru, Yu, Zhen, Xiong, Wen-Jie, Liu, Xu-Xiang, Liu, Hui-Min, Cui, Rui, Wang, Qi, Chen, Wen-Ming, Qiu, Lu-Gui, Yi, Shu-Hua
Publicado 2020

Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia

por Li, Heng, Yi, Shu-Hua, Xiong, Wen-Jie, Liu, Hui-Min, Lyu, Rui, Wang, Ting-Yu, Liu, Wei, Zhong, Shi-Zhen, Yu, Zhen, Zou, De-Hui, Xu, Yan, An, Gang, Li, Zeng-Jun, Qiu, Lu-Gui
Publicado 2017

Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study

por Cao, Xin-xin, Jin, Jie, Fu, Cheng-cheng, Yi, Shu-hua, Zhao, Wei-li, Sun, Zi-min, Yang, Wei, Li, Deng-ju, Cui, Guo-hui, Hu, Jian-da, Liu, Ting, Song, Yong-ping, Xu, Bing, Zhu, Zun-min, Xu, Wei, Zhang, Ming-zhi, Tian, Ya-min, Zhang, Bin, Zhao, Ren-bin, Zhou, Dao-bin
Publicado 2022